Skip to content

The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position

The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01546636
Enrollment
70
Registered
2012-03-07
Start date
2010-11-30
Completion date
2013-07-31
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Ischemia

Keywords

Cerebral desaturation events, Cerebral oximetry, Beach chair position

Brief summary

The aim of this clinical investigation is to determine the effect of intraoperative ventilation on cerebral oxygen saturation in patients undergoing arthroscopic shoulder surgery in the beach chair position (BCP)

Detailed description

Recent developments in near-infrared spectroscopy technology now permit rapid assessment of cerebral oxygenation (SctO2) using non-invasive probes. A high incidence cerebral desaturation events (CDE-defined as a decrease in SctO2 values below 20% of baseline measures or absolute SctO2 values ≤ 55 for ≥ 15 seconds) have been observed in previous investigation of patients undergoing shoulder surgery in BCP with hyperventilation. The investigators hypothesize that the incidence of CDE will be reduced in patients ventilated at normocapnic levels (end-tidal carbon dioxide values (ETCO2) of 40-42 mm Hg) when compared to subjects hyperventilated (ETCO2 of 30-32 mm Hg) in the operating room. Patients undergoing shoulder surgery in the BCP will be randomized to a hypocapnic group (ETCO2 of 30-32 mm Hg) or a normocapnic group (ETCO2 of 40-42 mm Hg). Cerebral oxygenation will be measured continuously throughout the procedure to assess perioperative SctO2 values and the incidence of CDE. The investigators previously observed an association between CDE in the operating room and postoperative nausea and vomiting. Therefore, the effect of ventilatory pattern and intraoperative SctO2 on clinical recovery will also be determined.

Interventions

OTHERHypocapnic group

Patients will be ventilated to an ETCO2 of 30-32 mm Hg.

OTHERNormocapnic group

Patients will be ventilated to an ETCO2 of 40-42 mm Hg

Sponsors

Endeavor Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients presenting for elective shoulder arthroscopy under general anesthesia in the BCP.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Cerebral Desaturation EventsIntraoperative-first 2 hoursCerebral desaturation events were measured with near-infrared spectroscopy

Secondary

MeasureTime frameDescription
Number of Patients Experiencing Nausea and VomitingPostanesthesia care unit-first 2 hoursAssessed by recovery nurses
Postanesthesia Care Unit Length of Stay (Total Time)Approximately 5 hours

Countries

United States

Participant flow

Recruitment details

A total of 70 patients presenting for elective shoulder surgery at NorthShore University HealthSystem were enrolled in the clinical trial.

Pre-assignment details

All enrolled participants completed the study, and complete data was collected on all subjects.

Participants by arm

ArmCount
Hypocapnic Group
Patients will be ventilated to an ETCO2 of 30-32 mm Hg.
36
Normocapnic Group
Patients will be ventilated to an ETCO2 of 40-42 mm Hg
34
Total70

Baseline characteristics

CharacteristicNormocapnic GroupHypocapnic GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants5 Participants9 Participants
Age, Categorical
Between 18 and 65 years
30 Participants31 Participants61 Participants
Age, Continuous54.7 years
STANDARD_DEVIATION 12.4
52.3 years
STANDARD_DEVIATION 13.8
53.3 years
STANDARD_DEVIATION 12.8
Region of Enrollment
United States
34 participants36 participants70 participants
Sex: Female, Male
Female
24 Participants26 Participants50 Participants
Sex: Female, Male
Male
10 Participants10 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 360 / 34
serious
Total, serious adverse events
0 / 360 / 34

Outcome results

Primary

Incidence of Cerebral Desaturation Events

Cerebral desaturation events were measured with near-infrared spectroscopy

Time frame: Intraoperative-first 2 hours

ArmMeasureValue (NUMBER)
Hypocapnic GroupIncidence of Cerebral Desaturation Events19 number of events
Normocapnic GroupIncidence of Cerebral Desaturation Events3 number of events
Secondary

Number of Patients Experiencing Nausea and Vomiting

Assessed by recovery nurses

Time frame: Postanesthesia care unit-first 2 hours

ArmMeasureValue (NUMBER)
Hypocapnic GroupNumber of Patients Experiencing Nausea and Vomiting12 participants
Normocapnic GroupNumber of Patients Experiencing Nausea and Vomiting3 participants
Secondary

Postanesthesia Care Unit Length of Stay (Total Time)

Time frame: Approximately 5 hours

ArmMeasureValue (MEDIAN)
Hypocapnic GroupPostanesthesia Care Unit Length of Stay (Total Time)81.5 minutes
Normocapnic GroupPostanesthesia Care Unit Length of Stay (Total Time)69 minutes

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026